Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 844-324-4673
Summary
- Dr. Justin Taylor is an oncologist and physician-scientist in Miami, FL and is affiliated with the Sylvester Comprehensive Cancer Center. He received his medical degree from the University of New Mexico School of Medicine, completed Internal Medicine training at the Brigham and Women’s Hospital and Hematology/Oncology fellowship at Memorial Sloan Kettering Cancer Center and has been in practice for 6 years. He specializes in hematologic oncology.
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2011 - 2014
- University of New Mexico School of MedicineClass of 2011
Certifications & Licensure
- FL State Medical License 2020 - 2026
- NY State Medical License 2014 - 2022
- MA State Medical License 2011 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsRisk prediction for clonal cytopenia: multicenter real-world evidence.Zhuoer Xie, Rami Komrokji, Najla Al Ali, Alexandra Regelson, Susan Geyer
Blood. 2024-11-07 - 1 citationsData-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.Rami S Komrokji, Luca Lanino, Somedeb Ball, Jan P Bewersdorf, Monia Marchetti
The Lancet. Haematology. 2024-11-01 - Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic ...Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, John M Bennett, Rafael Bejar
Modern Pathology. 2024-09-23
Abstracts/Posters
- Aberrant RNA Splicing Contributes to the Pathogenesis of EVI-Rearranged Myeloid LeukemiasJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction ChemotherapyJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant LeukemiasJustin Taylor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024
- Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
- Ask the Experts: The Potential of Tyrosine Kinase Inhibitors in OncologyApril 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: